Natixis »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Natixis

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Natixis

Quarter filed Position value Share count Share price at filing
2023-09-30 $10M 11k 931.23

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Coinbase Global Com Cl A (COIN)
Strategy Cl A New (MSTR)
Energy Transfer Com Ut Ltd Ptn (ET)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Johnson & Johnson (JNJ)

View all positions for Natixis

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1